We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AQST icon
476
Aquestive Therapeutics
AQST
$488M
$488M $3.89 3.71%
DCTH icon
477
Delcath Systems
DCTH
$487M
$487M $14.04 4.1%
EVH icon
478
Evolent Health
EVH
$486M
$486M $4.30 1.18%
EOLS icon
479
Evolus
EOLS
$485M
$485M $7.35 2.26%
RCEL icon
480
Avita Medical
RCEL
$484M
$484M $15.65 6.34%
FTH icon
481
Faeth Therapeutics
FTH
$483M
$483M $18.69 0.32%
GYRE icon
482
Gyre Therapeutics
GYRE
$482M
$482M $4.55 29%
RGNX icon
483
Regenxbio
RGNX
$475M
$475M $7.20 2.83%
MNPR icon
484
Monopar Therapeutics
MNPR
$472M
$472M $70.32 2.21%
SSII icon
485
SS Innovations International
SSII
$471M
$471M $2.35 1.26%
PHAT icon
486
Phathom Pharmaceuticals
PHAT
$467M
$467M $5.74 7.72%
MASS icon
487
908 Devices
MASS
$465M
$465M $11.25 12.5%
CERS icon
488
Cerus
CERS
$459M
$459M $2.28 6.56%
BWAY icon
489
Brainsway
BWAY
$457M
$457M $11.36 4.78%
TKNO icon
490
Alpha Teknova
TKNO
$454M
$454M $7.36 9.02%
XPH icon
491
State Street SPDR S&P Pharmaceuticals ETF
XPH
$454M
$454M $64.80 0.58%
EPRX icon
492
Eupraxia Pharmaceuticals
EPRX
$451M
$451M $6.83 5.79%
PBE icon
493
Invesco Biotechnology & Genome ETF
PBE
$445M
$445M $102.50 0.93%
KMDA icon
494
Kamada
KMDA
$444M
$444M $7.70 3.14%
CRMD icon
495
CorMedix
CRMD
$444M
$444M $5.70 25.4%
BLSM
496
BlossomHill Therapeutics
BLSM
$437M
$437M $13.75 9.6%
PRTA icon
497
Prothena Corp
PRTA
$435M
$435M $8.47 4.62%
NPCE icon
498
Neuropace
NPCE
$422M
$422M $12.30 5.46%
MPLT icon
499
MapLight Therapeutics
MPLT
$421M
$421M $7.58 1.81%
YDES icon
500
YD Bio Ltd
YDES
$421M
$421M $5.94 1.19%
18 19
20
21 22

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,121 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $10T.

The largest by market cap are Eli Lilly (LLY) at $1.26T, Johnson & Johnson (JNJ) at $658B and AbbVie (ABBV) at $521B.

Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.

  • Combined market cap: $10T across 1,121 stocks.
  • Largest constituent: Eli Lilly (LLY), $1.26T market cap.
  • Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.